Excreted urinary glycans Analysis and diagnosis of kidney disease without renal Tissue specimens(Extant-2) Study -Multicenter Prospective study

Not Applicable

Recruiting

• Conditions: biopsy-proven renal diseases

• Registration Number: JPRN-UMIN000040811
• Lead Sponsor: Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-07-01
• Study Completion: 2023-03-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 1000

Inclusion Criteria

Not provided

Exclusion Criteria

1. Patients who decline the entry of this study. 2. Patients who are regarded as inappropriate for joining this study.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Clinical performance for differentiating kidney diseases by the combination of urinary glycan profiling and clinical tests (hematuria, proteinuria, serum IgA) (Sensitivity and Specificity)

Secondary Outcome Measures

Name	Time	Method
1) Clinical performance for differentiating kidney diseases by the combination of urinary glycan profiling and clinical tests (hematuria, proteinuria, serum IgA) (Accuracy and ROC-AUC) 2) Clinical performance for differentiating kidney diseases by urinary glycan profiling (Sensitivity and Specificity) 3) Clinical performance for differentiating the participants with kidney diseases in subgroups defined by eGFR (>= or <60 mL/min/1.73m2) by the combination of urinary glycan profiling and clinical tests (Sensitivity, Specificity, Accuracy, and ROC-AUC)